Atherosclerosis
Volume 188, Issue 2 , Pages 281-291 , October 2006

Functional mutations of the ABCA1 gene in subjects of French–Canadian descent with HDL deficiency

  • Khalid Alrasadi

      Affiliations

    • Authors contributed equally.
    • ,
  • Isabelle L. Ruel

      Affiliations

    • Authors contributed equally.
    • ,
  • Michel Marcil

      Affiliations

    • Corresponding Author InformationCorresponding authors at: Division of Cardiology, McGill University Health Center/Royal Victoria Hospital, Cardiology Division M4.72, 687 Pine Avenue West, Montreal, QC, Canada H3A 1A1. Tel.: +1 514 934 1934x34642; fax: +1 514 843 2813.
    • ,
  • Jacques Genest

      Affiliations

    • Corresponding Author InformationCorresponding authors at: Division of Cardiology, McGill University Health Center/Royal Victoria Hospital, Cardiology Division M4.72, 687 Pine Avenue West, Montreal, QC, Canada H3A 1A1. Tel.: +1 514 934 1934x34642; fax: +1 514 843 2813.

Received 7 October 2005 ,Revised 27 October 2005 ,Accepted 31 October 2005.

References 

  1. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis. 2000;153:263–272
  2. Genest JJ, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85:2025–2033
  3. Assmann G, Nofer JR. Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003;54:321–341
  4. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004;305:869–872
  5. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest. 2004;114:1343–1353
  6. Denis M, Haidar B, Marcil M, Bouvier M, Krimbou L, Genest J. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1). J Biol Chem. 2004;279:7384–7394
  7. Krimbou L, Hajj HH, Blain S, et al. Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines. J Lipid Res. 2005;46:1668–1677
  8. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22:336–345
  9. Marcil M, Brooks-Wilson A, Clee SM, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 1999;354:1341–1346
  10. Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999;22:352–355
  11. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347–351
  12. Brousseau ME, Bodzioch M, Schaefer EJ, et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 2001;154:607–611
  13. Clee SM, Zwinderman AH, Engert JC, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 2001;103:1198–1205
  14. Evans D, Beil FU. The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med. 2003;81:264–270
  15. Pajukanta P. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?. J Clin Invest. 2004;114:1244–1247
  16. Probst MC, Thumann H, Aslanidis C, et al. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis. 2004;175:269–279
  17. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol. 2003;23:1322–1332
  18. Srinivasan SR, Li S, Chen W, Boerwinkle E, Berenson GS. R219K polymorphism of the ABCA1 gene and its modulation of the variations in serum high-density lipoprotein cholesterol and triglycerides related to age and adiposity in white versus black young adults. The Bogalusa heart study. Metabolism. 2003;52:930–934
  19. Tregouet DA, Ricard S, Nicaud V, et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol. 2004;24:775–781
  20. Wang J, Burnett JR, Near S, et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol. 2000;20:1983–1989
  21. Yamakawa-Kobayashi K, Yanagi H, Yu Y, Endo K, Arinami T, Hamaguchi H. Associations between serum high-density lipoprotein cholesterol or apolipoprotein AI levels and common genetic variants of the ABCA1 gene in Japanese school-aged children. Metabolism. 2004;53:182–186
  22. NIH . Lipid Research Clinics population studies databook, NIH Publication 80-1527. Washington, DC: Department of Health and Human Services, Public Health Service; 1980;p. 28–81
  23. Marcil M, Bissonnette R, Vincent J, Krimbou L, Genest J. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency. Circulation. 2003;107:1366–1371
  24. Dastani Z, Dangoisse C, Boucher B, et al. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians. Atherosclerosis 2005.
  25. MacLean DR, Petrasovits A, Connelly PW, Joffres M, O’Connor B, Little JA. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol. 1999;15:434–444
  26. Weber M, McNicoll S, Marcil M, et al. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Can J Cardiol. 1997;13:253–260
  27. Brousseau ME, Schaefer EJ, Dupuis J, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds. J Lipid Res. 2000;41:433–441
  28. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem. 2002;277:33178–33187
  29. Singaraja RR, Bocher V, James ER, et al. Human ABCA1 BAC transgenic mice show increased high-density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem. 2001;276:33969–33979
  30. Choi HY, Karten B, Chan T, et al. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem. 2003;278:32569–32577
  31. Lee CY, Krimbou L, Vincent J, et al. Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. Hum Genet. 2003;112:552–562

PII: S0021-9150(05)00724-0

doi: 10.1016/j.atherosclerosis.2005.10.048

Atherosclerosis
Volume 188, Issue 2 , Pages 281-291 , October 2006

Article Tools

* Image Usage & Resolution